Australia's largest stock trading and investment forum Australia's #1 stock forum

MBH

9.52%

6.9¢ maggie beer holdings ltd

50 cents, still be cheap, page-5

First 5 Last

Share
Profile

Follow
Watermelon7

565 Posts.

139

30/10/20

19:20

Post #: 48541158
Share

Originally posted by spider5: ↑

In April 2018 prior to the consolidation of shares in Longtable the SP of this company was 4c - the consolidation took the share price to $1. Since that time the company has bought St Davids dairy, had a CR and purchased all of the remaining Maggie Beer holdings. They are now growing without the need for a CR. Seems incongruous that they can come so far but still only be valued at 31c just one third of their price as a fledgling. So yes I agree that 50c is a very probable price based on past judgements as to their value. I have taken mine out of the bottom draw and they are now back on daily watch.

Expand

Here's an idea...
Pay a fair sp and forgo a .5c reduction...
50c b4 Christmas!

MBH Price at posting: 33.5¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 2 more messages in this thread...

First 5 Last

Add MBH (ASX) to my watchlist

(20min delay)
Last 6.9¢		Change 0.006(9.52%)		Mkt cap ! $24.43M

Open	High	Low	Value	Volume
6.6¢	6.9¢	6.6¢	$15.63K	232.2K

Buyers (Bids)

No.	Vol.	Price($)
1	182570	6.3¢

Sellers (Offers)

Price($)	Vol.	No.
6.7¢	3042	1

View Market Depth

No.	Vol.	Price($)
1	33724	0.062
1	44067	0.059
1	80000	0.057
2	7500	0.055
1	50000	0.054

Price($)	Vol.	No.
0.067	3042	1
0.069	1194	1
0.070	66666	1
0.071	14075	1
0.072	66666	1

Last trade - 12.11pm 04/10/2024 (20 minute delay)

MBH (ASX) Chart

50 cents, still be cheap, page-5

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

50 cents, still be cheap, page-5

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News